HoLEP、PKRP治療良性前列腺增生癥臨床效果比較
發(fā)布時間:2018-12-12 05:59
【摘要】:目的比較經尿道鈥激光前列腺剜除術(HoLEP)、等離子前列腺電切術(PKRP)治療良性前列腺增生癥(BPH)的臨床效果。方法 BPH患者202例,其中行HoLEP者115例、行PKRP者87例,比較兩組臨床效果。結果與PKRP組比較,HoLEP組手術時間、膀胱沖洗時間、留置尿管時間、住院時間均縮短,血紅蛋白下降幅度小,切除標本重量大(P均0.05)。與PKRP組比較,HoLEP組T1國際前列腺癥狀評分(IPSS)、殘余尿(PVR)改善幅度明顯,T2IPSS、生活質量評分、最大尿流率、PVR改善明顯(P均0.05)。與PKRP組比較,HoLEP組圍術期總并發(fā)癥較低(P0.05)。結論 HoLEP、PKRP治療BPH均可取得良好療效,且較為安全;但HoLEP較PKRP可減少手術時間、膀胱沖洗時間、留置尿管時間、住院時間,提高患者生活質量,且總并發(fā)癥發(fā)生率減少。
[Abstract]:Objective to compare the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP),) plasma prostatectomy (PKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods 202 patients with BPH were treated with HoLEP (115 cases) and 87 cases with PKRP (87 cases). Results compared with PKRP group, the operation time, bladder irrigation time, indwelling time and hospitalization time of HoLEP group were all shortened, hemoglobin decreased slightly, and the weight of excision specimen was larger (P 0.05). Compared with PKRP group, T1 international prostatic symptom score of HoLEP group showed significant improvement in (PVR) residual urine, T2IPSS, quality of life score, maximum flow rate and PVR improved significantly (all P 0.05). Compared with PKRP group, the total perioperative complications in HoLEP group were lower (P0.05). Conclusion HoLEP,PKRP is safe and effective in the treatment of BPH, but HoLEP can reduce the operation time, bladder irrigation time, indwelling urinary catheter time, hospitalization time, improve the quality of life of patients, and reduce the incidence of total complications.
【作者單位】: 三峽大學第一臨床醫(yī)學院;三峽大學泌尿外科研究所;
【分類號】:R699.8
,
本文編號:2374050
[Abstract]:Objective to compare the clinical effects of transurethral holmium laser enucleation of the prostate (HoLEP),) plasma prostatectomy (PKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods 202 patients with BPH were treated with HoLEP (115 cases) and 87 cases with PKRP (87 cases). Results compared with PKRP group, the operation time, bladder irrigation time, indwelling time and hospitalization time of HoLEP group were all shortened, hemoglobin decreased slightly, and the weight of excision specimen was larger (P 0.05). Compared with PKRP group, T1 international prostatic symptom score of HoLEP group showed significant improvement in (PVR) residual urine, T2IPSS, quality of life score, maximum flow rate and PVR improved significantly (all P 0.05). Compared with PKRP group, the total perioperative complications in HoLEP group were lower (P0.05). Conclusion HoLEP,PKRP is safe and effective in the treatment of BPH, but HoLEP can reduce the operation time, bladder irrigation time, indwelling urinary catheter time, hospitalization time, improve the quality of life of patients, and reduce the incidence of total complications.
【作者單位】: 三峽大學第一臨床醫(yī)學院;三峽大學泌尿外科研究所;
【分類號】:R699.8
,
本文編號:2374050
本文鏈接:http://www.sikaile.net/yixuelunwen/mjlw/2374050.html
最近更新
教材專著